- Home
- NMM vs CLDX Comparison
NMM vs CLDX Comparison
Compare NMM & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMM
- CLDX
- Stock Information
- Founded
- NMM 2007
- CLDX N/A
- Country
- NMM Greece
- CLDX United States
- Employees
- NMM N/A
- CLDX N/A
- Industry
- NMM Marine Transportation
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NMM Consumer Discretionary
- CLDX Health Care
- Exchange
- NMM Nasdaq
- CLDX Nasdaq
- Market Cap
- NMM 1.4B
- CLDX 1.6B
- IPO Year
- NMM 2007
- CLDX 2008
- Fundamental
- Price
- NMM $48.42
- CLDX $24.46
- Analyst Decision
- NMM Strong Buy
- CLDX Strong Buy
- Analyst Count
- NMM 1
- CLDX 9
- Target Price
- NMM $80.00
- CLDX $46.13
- AVG Volume (30 Days)
- NMM 119.4K
- CLDX 1.5M
- Earning Date
- NMM 11-04-2025
- CLDX 11-05-2025
- Dividend Yield
- NMM 0.41%
- CLDX N/A
- EPS Growth
- NMM N/A
- CLDX N/A
- EPS
- NMM 10.24
- CLDX N/A
- Revenue
- NMM $1,305,026,000.00
- CLDX $5,790,000.00
- Revenue This Year
- NMM N/A
- CLDX N/A
- Revenue Next Year
- NMM $7.93
- CLDX N/A
- P/E Ratio
- NMM $4.72
- CLDX N/A
- Revenue Growth
- NMM N/A
- CLDX N/A
- 52 Week Low
- NMM $28.37
- CLDX $14.40
- 52 Week High
- NMM $65.89
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- NMM 63.15
- CLDX 57.09
- Support Level
- NMM $47.11
- CLDX $24.02
- Resistance Level
- NMM $49.59
- CLDX $25.51
- Average True Range (ATR)
- NMM 1.11
- CLDX 1.16
- MACD
- NMM -0.12
- CLDX 0.14
- Stochastic Oscillator
- NMM 65.49
- CLDX 66.11
About NMM Navios Maritime Partners LP Common Units Representing Limited Partner Interests
Navios Maritime Partners LP is a seaborne shipping company. It owns and operates dry cargo and container vessels with the primary long-term and staggered expiration charters. The firm's fleet consists of Ultra- Handymax, Panamax, Capsize, and Container vessels and categorized in Drybulk and Container vessels. It earns revenue through the chartering of vessels and voyage contracts. Geographically, it generates majority revenue from Asia.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.